205 related articles for article (PubMed ID: 25195584)
1. Network measures for chemical library design.
Sukumar N; Krein MP; Prabhu G; Bhattacharya S; Sen S
Drug Dev Res; 2014 Sep; 75(6):402-11. PubMed ID: 25195584
[TBL] [Abstract][Full Text] [Related]
2. Computational approaches for drug discovery.
Hung CL; Chen CC
Drug Dev Res; 2014 Sep; 75(6):412-8. PubMed ID: 25195585
[TBL] [Abstract][Full Text] [Related]
3. Chemoinformatics and library design.
Zhou JZ
Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
[TBL] [Abstract][Full Text] [Related]
4. SEABED: Small molEcule activity scanner weB servicE baseD.
Fenollosa C; Otón M; Andrio P; Cortés J; Orozco M; Goñi JR
Bioinformatics; 2015 Mar; 31(5):773-5. PubMed ID: 25348211
[TBL] [Abstract][Full Text] [Related]
5. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
6. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery.
Reutlinger M; Schneider G
J Mol Graph Model; 2012 Apr; 34():108-17. PubMed ID: 22326864
[TBL] [Abstract][Full Text] [Related]
7. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
8. Integrating structure-based and ligand-based approaches for computational drug design.
Wilson GL; Lill MA
Future Med Chem; 2011 Apr; 3(6):735-50. PubMed ID: 21554079
[TBL] [Abstract][Full Text] [Related]
9. What is next for small-molecule drug discovery?
Doweyko AM; Doweyko LM
Future Med Chem; 2009 Sep; 1(6):1029-36. PubMed ID: 21425992
[TBL] [Abstract][Full Text] [Related]
10. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
11. Multi-objective optimization methods in drug design.
Nicolaou CA; Brown N
Drug Discov Today Technol; 2013 Sep; 10(3):e427-35. PubMed ID: 24050140
[TBL] [Abstract][Full Text] [Related]
12. NMR in structure-based drug design.
Carneiro MG; Ab E; Theisgen S; Siegal G
Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
[TBL] [Abstract][Full Text] [Related]
13. Ligand and decoy sets for docking to G protein-coupled receptors.
Gatica EA; Cavasotto CN
J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
[TBL] [Abstract][Full Text] [Related]
14. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
15. Applications of (19)F-NMR in Fragment-Based Drug Discovery.
Norton RS; Leung EW; Chandrashekaran IR; MacRaild CA
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438818
[TBL] [Abstract][Full Text] [Related]
16. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
[TBL] [Abstract][Full Text] [Related]
17. Hit finding: towards 'smarter' approaches.
Langer T; Hoffmann R; Bryant S; Lesur B
Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
[TBL] [Abstract][Full Text] [Related]
18. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
Roughley SD; Hubbard RE
J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
[No Abstract] [Full Text] [Related]
19. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
[TBL] [Abstract][Full Text] [Related]
20. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
